FBXW7 acts as a tumor suppressor involved in the degradation of substrates with oncogenic activity frequently overexpressed in breast cancer such as Cyclin E, c-Myc and AURKA [14, 29-31]. Here, FBXW7 is linked to breast carcinoma.